Form 8-K - Current report:
SEC Accession No. 0001437749-20-025295
Filing Date
2020-12-14
Accepted
2020-12-14 16:16:24
Documents
4
Period of Report
2020-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20201211_8k.htm 8-K 28716
2 EXHIBIT 1.1 ex_217514.htm EX-1.1 214247
3 EXHIBIT 3.1 ex_217515.htm EX-3.1 81518
4 EXHIBIT 4.1 ex_217516.htm EX-4.1 96466
  Complete submission text file 0001437749-20-025295.txt   422125
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 201386337
SIC: 2834 Pharmaceutical Preparations